Intuitive Surgical, Inc. (ISRG) — Fair Value Analysis
Base-case fair value (P50): $336.23 · Current price: $421.12 · Verdict: Overvalued
The Verdict on ISRG
Intuitive Surgical (ISRG) currently appears overvalued when assessed through Monte Carlo simulations. Trading at $452.86, the Healthcare sector stalwart's current market price significantly exceeds its median fair value. Our analysis indicates a median fair value (P50) of $361.48, implying a substantial -20.2% gap relative to the current trading level. This discrepancy suggests that market expectations may be running ahead of intrinsic valuation drivers. The Monte Carlo framework, simulating thousands of future scenarios, consistently places ISRG's fair value well below its present market quotation, pointing to potential downside for investors seeking entry at current levels.
How ISRG stacks up against Healthcare
Despite its market leadership within the Healthcare sector, Intuitive Surgical (ISRG) holds an average quality tier relative to its peers in terms of operational and financial health. This assessment, factored into our Monte Carlo simulations, indicates that while ISRG is a robust company, its fundamental strength does not fully justify the premium reflected in its current price of $452.86. An average quality rating suggests that while the company navigates its competitive landscape effectively, it doesn't possess the exceptional financial fortifications that might warrant a sustained premium well above its median fair value of $361.48. The -20.2% gap against its fair value becomes particularly pertinent when considering this benchmarked quality.
What this means for investors
For investors considering Intuitive Surgical (ISRG), the current valuation presents a clear challenge. With the stock trading at $452.86 and a median fair value of $361.48, the -20.2% overvaluation indicates that a downside scenario is statistically more probable based on our Monte Carlo analysis. While the Healthcare sector offers long-term growth prospects, ISRG's average quality tier suggests that its premium may be unsustainable without substantial, unforeseen improvements in fundamental performance. Prudent investors may wish to await a more favorable entry point, closer to or below the estimated fair value, to capture a more attractive risk-reward profile. To see the full bear/bull distribution and track ISRG's fair value as new fundamentals are released, sign up for FairCurve today.
Frequently Asked Questions
Is ISRG overvalued or undervalued right now?
Based on Monte Carlo simulations, Intuitive Surgical (ISRG) is currently considered overvalued. Its current price of $452.86 is significantly above its median fair value (P50) of $361.48.
What is the bear case and bull case for ISRG?
The full Monte Carlo distribution, including specific bear (P10) and bull (P90) target prices, along with the probability of upside, is available to users with a free FairCurve account.
How does FairCurve calculate ISRG's fair value?
FairCurve calculates ISRG's fair value through sophisticated Monte Carlo simulations, running thousands of forward scenarios to determine a comprehensive distribution of potential intrinsic values.
How can I track ISRG's fair value as it changes?
You can add ISRG to a free FairCurve watchlist to receive daily fair-value updates and instant re-valuation whenever new earnings or fundamental data are released.